ATE554770T1 - Therapeutisches mittel gegen entzündliche darmerkrankungen - Google Patents
Therapeutisches mittel gegen entzündliche darmerkrankungenInfo
- Publication number
- ATE554770T1 ATE554770T1 AT07737060T AT07737060T ATE554770T1 AT E554770 T1 ATE554770 T1 AT E554770T1 AT 07737060 T AT07737060 T AT 07737060T AT 07737060 T AT07737060 T AT 07737060T AT E554770 T1 ATE554770 T1 AT E554770T1
- Authority
- AT
- Austria
- Prior art keywords
- inflammatory bowel
- bowel disease
- therapeutic agent
- agent against
- against inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006110869 | 2006-04-13 | ||
PCT/JP2007/000403 WO2007122812A1 (ja) | 2006-04-13 | 2007-04-12 | 炎症性腸疾患治療薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE554770T1 true ATE554770T1 (de) | 2012-05-15 |
Family
ID=38624731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07737060T ATE554770T1 (de) | 2006-04-13 | 2007-04-12 | Therapeutisches mittel gegen entzündliche darmerkrankungen |
Country Status (12)
Country | Link |
---|---|
US (1) | US7820686B2 (de) |
EP (1) | EP2005962B1 (de) |
JP (1) | JP5058156B2 (de) |
KR (1) | KR101390144B1 (de) |
CN (1) | CN101420957B (de) |
AT (1) | ATE554770T1 (de) |
AU (1) | AU2007242332B2 (de) |
CA (1) | CA2649256C (de) |
ES (1) | ES2382673T3 (de) |
HK (1) | HK1127964A1 (de) |
TW (1) | TWI406858B (de) |
WO (1) | WO2007122812A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI429439B (zh) * | 2007-10-11 | 2014-03-11 | Taiho Pharmaceutical Co Ltd | And a therapeutic agent for inflammatory bowel disease using a uracil derivative as an active ingredient |
TWI435725B (zh) * | 2007-10-11 | 2014-05-01 | Taiho Pharmaceutical Co Ltd | The use of a uracil compound for a prophylactic or therapeutic composition for the preparation of cystitis and hepatitis |
TWI503122B (zh) * | 2012-02-15 | 2015-10-11 | Taiho Pharmaceutical Co Ltd | Oral administration of pharmaceutical compositions |
CN102920789A (zh) * | 2012-11-29 | 2013-02-13 | 中央民族大学 | 治疗溃疡性结肠炎的药物制剂蒙药嘎日迪及其制备方法 |
GEP20186841B (en) | 2013-06-17 | 2018-04-10 | Pharmaceutical Co Ltd Taiho | Stabilized crystal of tipiracil hydrochloride, and crystallization method for same |
BR112021001984A2 (pt) * | 2018-08-15 | 2021-05-11 | Pharmacyl Ab | composto, combinação, composição farmacêutica, conjunto de partes, uso de composto, e, método para tratamento de uma doença resultante de inflamação patológica |
CN110638803A (zh) * | 2019-10-24 | 2020-01-03 | 上海长海医院 | Dencichine在制备治疗炎性肠病药物中的用途 |
CA3159601A1 (en) * | 2019-11-20 | 2021-05-27 | Angion Biomedica Corp. | Methods for treating inflammatory bowel disease |
CN111686106B (zh) * | 2020-04-05 | 2022-07-15 | 温州医科大学附属第一医院 | 提高Dicer表达的化合物在制备药物中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0763529T3 (da) | 1995-03-29 | 2003-11-10 | Taiho Pharmaceutical Co Ltd | Uracilderivater og antitumorvirkningspotentiator og antitumormiddel indeholdende samme |
JP3746522B2 (ja) * | 1996-04-05 | 2006-02-15 | 麒麟麦酒株式会社 | イネ科植物の発芽種子由来のタンパク質および不溶性食物センイを含有する物質並びにその用途 |
AU699728B2 (en) * | 1996-09-24 | 1998-12-10 | Taiho Pharmaceutical Co., Ltd. | Cancerous metastasis inhibitors containing uracil derivatives |
JP4049477B2 (ja) | 1999-03-23 | 2008-02-20 | 大鵬薬品工業株式会社 | 副作用軽減剤 |
-
2007
- 2007-04-12 ES ES07737060T patent/ES2382673T3/es active Active
- 2007-04-12 JP JP2008511965A patent/JP5058156B2/ja not_active Expired - Fee Related
- 2007-04-12 CA CA2649256A patent/CA2649256C/en not_active Expired - Fee Related
- 2007-04-12 US US12/296,671 patent/US7820686B2/en not_active Expired - Fee Related
- 2007-04-12 WO PCT/JP2007/000403 patent/WO2007122812A1/ja active Application Filing
- 2007-04-12 TW TW096112890A patent/TWI406858B/zh not_active IP Right Cessation
- 2007-04-12 AU AU2007242332A patent/AU2007242332B2/en not_active Ceased
- 2007-04-12 CN CN2007800133586A patent/CN101420957B/zh not_active Expired - Fee Related
- 2007-04-12 AT AT07737060T patent/ATE554770T1/de active
- 2007-04-12 EP EP07737060A patent/EP2005962B1/de active Active
- 2007-04-12 KR KR1020087023029A patent/KR101390144B1/ko not_active IP Right Cessation
-
2009
- 2009-06-22 HK HK09105597.7A patent/HK1127964A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2007242332B2 (en) | 2012-02-02 |
TW200813025A (en) | 2008-03-16 |
JPWO2007122812A1 (ja) | 2009-09-03 |
EP2005962A2 (de) | 2008-12-24 |
US20090209565A1 (en) | 2009-08-20 |
TWI406858B (zh) | 2013-09-01 |
US7820686B2 (en) | 2010-10-26 |
EP2005962A9 (de) | 2009-07-15 |
WO2007122812A1 (ja) | 2007-11-01 |
AU2007242332A1 (en) | 2007-11-01 |
KR101390144B1 (ko) | 2014-04-28 |
JP5058156B2 (ja) | 2012-10-24 |
EP2005962B1 (de) | 2012-04-25 |
CN101420957A (zh) | 2009-04-29 |
CA2649256A1 (en) | 2007-11-01 |
CN101420957B (zh) | 2011-04-13 |
ES2382673T3 (es) | 2012-06-12 |
EP2005962A4 (de) | 2009-09-23 |
CA2649256C (en) | 2013-09-10 |
KR20080108999A (ko) | 2008-12-16 |
HK1127964A1 (en) | 2009-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE554770T1 (de) | Therapeutisches mittel gegen entzündliche darmerkrankungen | |
MY186986A (en) | Compositions and methods of use of phorbol esters | |
MA31663B1 (fr) | Dosage oral et interveineux de l'inhibiteur p2y12 reverisble et a action directe | |
AU2012243329A8 (en) | 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use | |
MY167560A (en) | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof | |
EA200901442A1 (ru) | Комбинированная терапия соединением, проявляющим активность ингибитора рецептора адф на тромбоцитах | |
MA30725B1 (fr) | Administration d'inhibiteurs de la dipeptidyl peptidase | |
IN2014CN02128A (de) | ||
AR088195A1 (es) | Composiciones farmaceuticas de n-metil-2-[3-(e)-2-piridin-2-il-vinil)-1h-indazol-6-ilsulfanil]-benzamida | |
WO2009051119A1 (ja) | ピリミジルインドリン化合物 | |
RU2010136914A (ru) | Средство и продукт питания для профилактики/уменьшения проявлений функционального расстройства пищеварения | |
AU2012286851A8 (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
MX2010002735A (es) | Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno. | |
WO2006130532A3 (en) | Treatment of liver diseases in which iron plays a role in pathogenesis | |
WO2007128086A3 (en) | Novel viral replication inhibitor | |
MX365313B (es) | Composición farmacéutica oral que comprende a,a,a-trifluorotimidin a y clorhidrato de 5-cloro-6-(2-iminopirrolidina-1-il)metil-2,4(1h ,3h)-pirimidina diona. | |
MX355885B (es) | Composición farmacéutica de administración oral. | |
WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
MY163762A (en) | Therapeutic agent for chronic renal failure | |
MA33563B1 (fr) | 5-(3,4-dichloro-phényl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-éthoxy)-nicotinamide et ses sels utilisés comme agents augmentant le cholestérol hdl | |
WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
WO2007092469A3 (en) | Combination of organic compounds | |
MA32498B1 (fr) | Compositions pharmaceutiques de rosuvastatine calcium | |
UY30847A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use |